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Abstract
Background: Association of particulate matter with adverse health effects has been established in epidemiological
studies and animal experiments. Epidemiological studies are difficult to undertake while animal studies are
impractical for high-throughput toxicity testing. The ease and rapidity of in vitro tests emphasizes their potential
for use in risk assessment of chemicals and particles. We examined the association between in vitro and in vivo
responses to ambient particles, to determine the potential of cell-based assays as standalone toxicity screening
tools.
Methods: Assays of cytotoxicity and key inflammatory mediators were applied to determine the in vitro biological
potency of a panel of urban and mineral particles in J774A.1 macrophages and A549 lung epithelial cells. The particles
were also screened for the presence of AhR agonists using the Ah receptor-dependent gene induction assay and for
endotoxin using the Limulus amebocyte lysate assay. A subset of the particles with a contrasting in vitro toxicity profile
was delivered intratracheally in BALB/c mice to assess their in vivo biological potency. Results from various bioassays
were combined within the in vitro and in vivo models. The combined potency measures were examined for
associations.
Results: Overall, J774A.1 cells were more sensitive to particle effects than A549 cells. Whereas the combined
cytotoxicity estimates were highly correlated between the two cell lines, the combined in vitro inflammatory
potency estimates were not, emphasizing functional differences of the two cell types. Secretion of inflammatory
markers by J774A.1 cells was correlated with AhR ligand binding profile and endotoxin levels of particles. Particle
instillation led to an acute toxicity response in BALB/c mice, with neutrophilia and release of inflammatory
mediators. While the combined toxicity estimates were not correlated between in vitro and in vivo models, the
combined inflammatory and integrated potency estimates (toxicity and inflammation) approached the threshold
for significance (p = 0.052) in a correlation within in vitro and in vivo models, with a ranking of fine particle
(DWR1), minerals (TiO2, CRI) and coarse particles (SRM-, EHC-type) from low to high potency.
Conclusion: Integration of in vitro endpoints shows promise in determining adverse outcomes of particle
exposures in vivo. The devised data reduction and computational approach will prove useful in the development
of models for assessment of hazard potential of particles; however, distinct models may be needed for particles
of different type, such as urban particles vs. mineral particles, nanomaterials.
Keywords: Particulate matter, Cytotoxicity, Inflammation, In vitro, In vivo, Aryl hydrocarbon receptor, Endotoxin,
Correlation
* Correspondence: renaud.vincent@hc-sc.gc.ca
1Inhalation Toxicology Laboratory, Hazard Identification Division, Healthy
Environments and Consumer Safety Branch, Health Canada, Ottawa, ON,
Canada
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Breznan et al. Particle and Fibre Toxicology  (2016) 13:41 
DOI 10.1186/s12989-016-0152-6
Background
Air pollution continues to exert a societal burden by
impacting multiple aspects of human health, especially
through its association with cardiopulmonary morbidity
and mortality [1]. Exposure to airborne particulate matter
is epidemiologically associated with increased incidence of
cardiopulmonary disease and lung cancer in humans
[2, 3]. Moreover, recent studies provide indications
that the health impacts of exposure to air pollutants may
be more widespread, including epidemiological associa-
tions with inflammatory bowel disease and non-specific
abdominal pain [4, 5], neuropathologies and cognitive
impairment [6, 7], alterations of markers of placental
growth and function, and adverse birth outcomes [8, 9], as
well as diabetes mellitus [10, 11].
Urban air particles are complex mixtures of chemical
and biogenic constituents associated with natural and an-
thropogenic particle sources and their modification in the
atmosphere. Increasing evidence shows that in addition to
size, chemical composition of the particles plays an im-
portant role in determining their hazard potential. Mitiga-
tion of specific constituents of air pollution mixtures and
particles with highest hazard potential may present a
reasonable regulatory strategy for reduction of adverse
population health effects.
Both, in vitro and in vivo approaches are widely utilized
for the study of the adverse effects of chemicals and
inhaled environmental pollutants by employing individual
endpoint assays to determine the adverse effects of par-
ticulate materials or to examine specific biological mecha-
nisms of toxicity. Animal studies have been generally
accepted as a major approach in the regulatory risk assess-
ment regimes [12–14]. Despite the definitive applicability
of in vivo methods to hazard evaluation and risk assess-
ment, issues such as low-throughput, high cost and ethical
aspects of animal use hinder their practicality as a toxicity
screening tool for large panels of airborne particulates and
chemicals. In vitro assays are better suited as screening
tools for hazard identification and determination of
toxicity, as they are amenable to automation and high-
throughput, are cost effective and greatly reduce the
dependence on animal use [13, 15, 16]. However, system-
atic evaluations of the predictive potential of in vitro
assays for adverse in vivo impacts of particulate matter are
required.
Few attempts have been made to conduct more compre-
hensive in vitro/in vivo evaluations of panels of particles
and particle fractions including gasoline and diesel engine
emission organic fractions [17, 18], polyurethane filter-
extracted particle suspensions [19], stone particles [20]
and nanoparticles [21]. These studies were met with
mixed success, whereby the correlations between in vitro
and in vivo measurements were poor, with a general lack
of rank order of particle hazard potency for organic
fractions of gasoline and diesel emissions and for nano-
scale particles [17, 18, 21]. In contrast, in vitro inflamma-
tory markers were generally well correlated with in vivo
inflammation models of exposure to ambient particles
from different emission sources, but not with in vivo
respiratory allergy models [19]. Correlations were also
observed between in vitro cytokines and in vivo neutrophil
counts in lung lavage from rats instilled with mineral
stone particles [20]. The lack of consistency between the
studies emphasizes the need for further standardization of
in vitro approaches, including variables such as culture
conditions, time course, choice of a wide range of bioas-
says, particle types, and the validation against relevant
in vivo effects.
The usefulness of in vitro studies is highlighted by
demonstrations of coherence of the particle-induced bio-
logical effects in cultured cells with in vivo responses
from a controlled human exposure study [22] and with
concomitant epidemiological observations of associa-
tions of Utah Valley hospital respiratory admissions and
PM10 emissions from a local steel mill source [23]. Parti-
cles extracted from filters collected from the Utah Valley
before, during, and after a temporary closure of a steel
mill differentially induced neutrophilia and IL-8 produc-
tion in human subjects instilled with the particles via
bronchoscopy. Interleukin-8 production was also stimu-
lated in human airway epithelial cells exposed to the
same particles in a corresponding manner, with a com-
parable potency profile [22].
In the present study, we assessed the toxicity and in-
flammatory potential of a panel of airborne particulates
and reference particles in cell lines in vitro and in
BALB/c mice exposed in vivo to particles at 24 h post-
intratracheal instillation. An approach was developed to
summarize large datasets to facilitate a comparison be-
tween the in vitro and in vivo responses to particles and
to evaluate the level of concordance between the two
models for toxicity testing.
Methods
Particulate materials
The particulate preparations SRM-1648 (St. Louis total
suspended particles, TSP; urban particulate matter refer-
ence material), SRM-1649a (Washington TSP; organics),
SRM-1879 (cristobalite, SiO2 reference material) and
SRM-154b (fine titanium dioxide; TiO2 reference mater-
ial) were obtained from the National Institute of Standards
and Technology (Gaithersberg, MD, USA). Cristobalite
particles will be referred to as CRI throughout the manu-
script. The TiO2 particles were washed in methanol and
phosphate buffered saline (PBS) to remove potential
naphthalene contaminant [24]. The PM2.5 DWR1 particles
were collected in Toronto as described before [24]. The
urban TSP preparations EHC-93, EHC-98 and EHC-2000
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refer to materials collected in Ottawa as described before
[25]. Particulate materials were weighed and resuspended
in sterile particle preparation solution (Tween-80, 25 μg/
mL; NaCl, 0.19 % w/v) to a concentration of 10 mg/mL
using a Dounce glass homogenizer. After vortexing, the
particle suspensions were sonicated in ice-cold water for
20 min and homogenized with 25 full strokes of the
homogenizer piston. The particle stocks were aliquoted
into sterile centrifuge tubes with O-ring seals and steril-
ized in a water bath at 56 °C for 30 min. These were kept
frozen at −80 °C, until use [26]. All materials were
analyzed for endotoxin using the chromogenic Limulus
amebocyte lysate assay (Lonza, Walkersville, MD, USA).
The materials EHC-93, EHC-98, EHC-2000 (Ottawa),
SRM-1648 (St. Louis) and SRM-1649 (Washington) are
TSP matter from urban environments, characterized by en-
richment in elements including aluminium (20–30 mg/g),
calcium (26–128 mg/g), iron (16–30 mg/g), magnesium
(9–16 mg/g), lead (5–14 mg/g), titanium (2–3 mg/g) and
zinc (2–11 mg/g), in the milligram per gram range. DWR1
is a PM2.5, with 10–100-fold less components from crustal
origin, e.g. aluminium (0.8 mg/g), iron (1 mg/g), magne-
sium (1.4 mg/g), lead (0.05 mg/g), titanium (0.06 mg/g).
SiO2 and TiO2 are mineral particles containing a variety of
trace elements. Available physicochemical information from
in-house analysis and NIST Certificates of Analysis are
presented in supplemental information (Additional file 1:
Table S1).
Cell culture
A549 human alveolar type II epithelial (Caucasian male,
lung carcinoma) and J774A.1 murine monocyte/macro-
phages (BALB/c female, cell sarcoma) cell lines were from
ATCC (Manassas, VA, USA). H1L1.1c2 murine hepatoma
cells containing a stably transfected Ah receptor-dependent
luciferase reporter gene were described elsewhere [27].
A549 were cultured in M199 with 2 mM L-glutamine and
10 % FBS (Invitrogen-Gibco, Burlington, ON, Canada).
J774A.1 were cultured in DMEM medium (Thermo-Fisher,
Nepean, ON, Canada) with 2 mM L-glutamine, 4.5 g/L
glucose and 10 % FBS. H1L1.1c2 cells were cultured in
MEM Alpha medium (Thermo-Fisher) supplemented with
10 % FBS and 2 mM L-glutamine. For all cytotoxicity
assays except BrdU incorporation, cells were seeded in
96-well (0.3 cm2 well) plates at cell densities of 4 × 104
(A549) and 8 × 104 cells/cm2 (J774A.1). For BrdU in-
corporation, cells were seeded at 1 × 104 (A549) and
2 × 104 cells/cm2 (J774A.1). For the LDH assay, A549
and J774A.1 cells were cultured in serum-free media
supplemented with 2 mM L-glutamine, 4.5 g/L glucose
(J774A.1 cells only) and 6 mg/mL BSA. H1L1.1c2 cells
were seeded in 24-well (0.5 cm2 well) plates at a density
of 1 × 104 cells per well, in 1 mL of complete medium.
The cells were then incubated for 24 h at 37 °C in 5 %
CO2 and 100 % relative humidity for attachment.
In vitro exposure to particles
Particle suspensions were thawed to room temperature
and sonicated for 20 min in ice-cold, ultrasonic water
bath, and diluted (1–2 mg/mL) in complete media de-
void of serum for dosing cells. The diluted particle sus-
pensions were sonicated for 5 min in an ice-cold,
ultrasonic water bath prior to dosing the cells. A549,
J774A.1 and H1L1.1c2 cell monolayers were dosed with
a 100 μL suspension of particles resulting in 0, 10, 20,
40, 80 and 100 μg/well (0, 30, 60, 120, 240 and 480 μg/
cm2) in a final volume of 200 μL/well, 5 % FBS. The
A549 and J774A.1 cell culture plates were incubated at
37 °C for 24 h before the cytotoxicity measurements
were carried out. Culture plates containing H1L1.1c2
cells were incubated at 37 °C for 4 h before they were
assayed for induction of aryl hydrocarbon response.
Cytotoxicity assessment
Following 24 h incubation with particles, A549 and
J774A.1 cells were assayed for cytotoxicity using resa-
zurin reduction assay (Alamar Blue), ATP assay, BrdU
incorporation assay and lactate dehydrogenase (LDH)
assay, and in H1L1.1c2 cells for Ah receptor-dependent
gene induction, as briefly outlined below. Assays were per-
formed using aliquots from cell culture supernatants and
lysates that were clarified by centrifugation to remove the
remnants of particles that could potentially interfere with
the assay reagent chemistry and detection methods. The
approach utilized has been previously described [28]. ATP
assay was performed by top reading.
Resazurin reduction assay
The spent medium was collected and replaced with
100 μL of fresh complete medium containing a 1:10 di-
lution of Resazurin (Alamar Blue) reagent (Biosource,
Camarillo, CA, USA) and fluorescence was measured at
λEx 530/25 nm and λEm 590/35 nm using Cytofluor
2350 fluorometer [28], 5 min and 2 h after incubation
at 37 °C, 5 % CO2). Rate of reduction is the delta fluor-
escence at 2 h – 5 min. Five independent experiments
were conducted (n = 5), with triplicate wells within each
experiment.
ATP assay
Cellular ATP content was assessed using the ViaLight
Plus assay (Lonza, Walkersville, MD, USA). Cells were
lysed with 10 μL of the assay cell lysis reagent for
10 min, followed by 25 μL of ATP-monitoring reagent
(AMR) containing firefly luciferase, luciferin, pyrophos-
phate, BSA and magnesium ions. After 2 min incubation
in the dark, the cellular ATP content was determined by
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top reading luminescence measurements using LMax
luminometer. Luminescence (rate of photon emission) is
directly proportional to concentration of ATP substrates).
The ATP assay was performed in three independent ex-
periments (n = 3), with triplicate wells within each
experiment.
BrdU incorporation
Following exposure to particles, 5-bromo-2-deoxyuridine
(BrdU) was added to each well at 100 μM and the cells
were returned to the incubator for 2 h. The culture
medium was removed by inversion of the 96-well
plates, and the cells were fixed for 30 min at room
temperature using the FixDenat solution (Roche Diag-
nostics, Indianapolis, IN, USA). The cells were washed
with blocking buffer (1 % BSA in PBS), followed by an
incubation with 100 μL of anti-BrdU antibody conju-
gated with peroxidase (anti-BrdU-POD, Fab fragments)
for 90 min at room temperature. After extensive wash-
ing, cells were incubated with 100 μL of the 3,3’,5,5’-
tetramethylbenzidine (TMB) chromogenic substrate for
10 min at room temperature in the dark, and the reaction
product was quantified at 370 nm using SpectraMax Plus
spectrophotometer. Three independent assays (n = 3),
with triplicate wells within each assay were conducted.
LDH assay
Culture supernatants were recovered and the cells were
lysed by a rapid freeze-thaw cycle. LDH activity was
measured in the clarified supernatants and the cell lysates
by spectrophotometry at 450 nm (SpectraMax Plus) from
production of NADH from lactate coupled with the in-
stantaneous conversion of tetrazolium to a red formazan
by NADH diaphorase (CytoTox 96 assay, Promega, Madi-
son, WI, USA). Release of cellular LDH was determined
from activity in supernatant over total LDH (supernatant
plus lysate). Three (A549, n = 3) or four (J774A.1, n = 4)
independent assays, with triplicate wells within each ex-
periment were conducted.
Assay of Ah receptor-dependent gene induction
After dosing with particles, H1L1.1c2 cell plates were
incubated at 37 °C for 4 h, followed by two washes in
ice-cold PBS, and 15 min lysis on ice using 50 μL/well of
luciferase assay system (Promega Corporation) lysis buf-
fer, on a plate shaker (250 rpm). The lysates were trans-
ferred to v-bottom plates and centrifuged at 3000 × g
(2 min, 4 °C) using a Sorvall Legend RT centrifuge.
Clarified cell lysates (25 μL) were transferred into a
white, clear-bottomed 96-well plate, 50 μL of luciferase
substrate was added by injection using an L-Max lumin-
ometer, followed by 15 s integrated luminescence reading
per well. Three independent experiments were conducted
(n = 3), with triplicates within each experiment.
Cytokine secretion in vitro
Cell culture supernatants of A549 cells were assessed for
Interleukin (IL)-1β (0.13 ± 0.01 pg/mL basal level in
control cells ± standard error mean), IL-1ra (n.d.; not
detected), IL-2 (n.d.), IL-4 (n.d.), IL-5 (n.d.), IL-6
(430 ± 111), IL-7 (n.d.), IL-8 (200 ± 4), IL-9 (n.d.), IL-10
(12.5 ± 1.9), IL-12 (p70) (n.d.), IL-13 (n.d.), IL-15 (n.d.), IL-
17 (n.d.), basic Fibroblast Growth Factor (FGF) (n.d.),
Eotaxin (n.d.), Granulocyte Colony-Stimulating Factor (G-
CSF) (n.d.), Granulocyte Macrophage Colony-Stimulating
Factor (GM-CSF) (2.8 ± 0.4), Interferon (IFN)-γ (n.d.),
IFN-γ Inducible Protein (IP)-10 (n.d.), Monocyte/Macro-
phage Chemoattractant Protein (MCP)-1 (701.5 ± 44.8),
Macrophage Inflammatory Protein (MIP)-1α (n.d.), MIP-
1β (0.9 ± 0.5), Platelet-Derived Growth Factor (PDGF)-BB
(n.d.), Regulated on Activation, Normal T cell Expressed
and Secreted (RANTES) (n.d.), Tumor Necrosis Factor
(TNF)-α (0.1 ± 0.1), and Vascular Endothelial Growth
Factor (VEGF) (n.d.), while cell culture supernatants of
J774A.1 were assessed for IL-1α (1.2 ± 0.1), IL-1β (5.9 ±
1.8), IL-2 (n.d.), IL-3 (n.d.), IL-4 (n.d.), IL-5 (n.d.), IL-6
(9.2 ± 1.0), IL-9 (n.d.), IL-10 (12.5 ± 1.9), IL-12 (p40) (n.d.),
IL-12 (p70) (n.d.), IL-13 (n.d.), IL-17A (n.d.), Eotaxin
(n.d.), G-CSF (n.d.), GM-CSF (9.4 ± 1.3), IFN-γ (n.d.),
Keratinocyte Chemoattractant (KC) (n.d.), MCP-1 (n.d.),
MIP-1α (above assay limit), MIP-1β (n.d.) and RANTES
(239 ± 28) using Bio-Plex cytokine panels (Bio-Rad La-
boratories, Mississauga, ON, Canada), with a Bio-Plex 200
array system.
In vivo exposures to particles
Seven weeks-old, pathogen-free BALB/c male mice (~25 g)
were from Charles-River (Saint-Constant, QC, Canada).
Mice were housed in shoe-box plexiglass cages, on wood-
chip bedding, provided with mouse chow and water ad
libitum, maintained under HEPA air filtration at 22 +/−
2 °C, ~50 % humidity and were held to a 12-h light/
dark cycle. The animals were acclimatized for at least
1 week prior to experimentation. The animal treatment
protocol was reviewed and approved by the Animal
Care Committee of Health Canada. The particle prepa-
rations were thawed at room temperature, sonicated for
10 min, diluted in saline and instilled intratracheally
(50 μL volume) using the MicroSprayer aerosolizer
(Penn-Century, Philadelphia, PA, USA) at doses of 0,
50, 100, 250 μg into anaesthetized mice in supine pos-
ition on an angled stand (n = 5 animals per dose). Mice
were euthanized after 24 h, bronchioalveolar lavage
(BAL) fluid and blood plasma were obtained as described
before [25]. BAL cells were counted and differential cy-
tology (Wright-Giems stain) was determined on CytoSpin
preparations (Thermo Shandon, Pittsburgh PA, USA) pre-
pared on glass slides using the Cytospin 3 centrifuge. Cell
differential counts of alveolar macrophages, neutrophils,
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lymphocytes, monocytes, eosinophils, basophils and band
cells (immature neutrophils) were determined from a pair
of slides for each animal. Fold change (i.e. treatment/
control) of the cell counts are presented. The values are
based on the percentage of cell type in a differential
profile multiplied by the total cell number (calculated
as cell # per ml BAL × volume of instilled lavage fluid
in the animal) to obtain an estimate of the absolute
number of the cell types recovered from lavage.
Biochemical assays in vivo
8-Isoprostaglandin-2a (Isoprostane) was quantitated from
blood plasma samples by competitive Enzyme Immuno-
Assay (EIA) following manufacturer-recommended proce-
dures (Cayman Chemical, Ann Arbor, MI, USA). LDH in
BAL was analyzed essentially as described for cell cultures.
Total protein was measured by the Coomassie Plus
(Bradford) assay as per manufacturer’s protocol (Pierce,
Rockford, IL, USA).
Cytokine secretion in vivo
The profile of IL-1α (0.1 ± 0.1 pg/mL basal level in con-
trol cells ± standard error mean), IL-1β (1.3 ± 0.2), IL-4
(n.d.; not detected), IL-5 (0.5 ± 0.5), IL-6 (0.1 ± 0), IL-10
(0.3 ± 0.13), GM-CSF (1.3 ± 0), KC ((3.8 ± 0.9), MIP-1α
(25.4 ± 8.8), RANTES (0.3 ± 0.2) and TNF-α (3.7 ± 1.0)
was determined by Bio-Plex analyses of BAL samples
using Bio-Plex cytokine panels, with a Bio-Plex 200 array
system. Basal levels in control cells are in parentheses
above and represent pg/mL ± standard error mean mea-
sured in cell culture supernatants and n.d. denotes
cytokine/chemokine not detected.
Particle potency estimates
The dose–response data for cell viability, cytokine secretion
and Ah receptor-dependent gene induction (AhR response
was scaled by dividing 20-fold to relate its magnitude to the
other endpoints), were normalized within an experiment
for all doses (including 0 μg dose control), to the grand
mean value of all controls (0 μg dose of particles), to obtain
fold-effect (FE) for each particle dose. Potency (β) was
derived from
FE ¼ Dose þ 1ð Þβ
where β is the rate of change of dose with respect to the
logarithm of fold-effect for a given endpoint [24]. The
dose–response data were fitted using CurveExpert v1.3
(D. Hyams, Hixson, TN, USA).
The following potencies were calculated: potency for
viability (βV) in a given assay, potency for Ah receptor-
dependent gene induction (βAhR), and potencies for
secretion of a cytokine (βI). βI was adjusted for cell
viability according to
βI−V ¼ βI−βV
where βI-V represents an unbiased potency estimate that
allows distinction of apparent down-regulation of a
cytokine from the absence of cytokine secretion by
dead cells, or an apparent up-regulation of cytokine
expression in cells simply due to an increase of cell
mass in the wells.
The potencies were combined as follows;
1) An average cytotoxic potency in each cell line
was calculated using assay specific potencies
according to:
βVA549 ¼ Average βV LDH A549; βV AB A549; βV ATP A549; βV BRDU A549
 
βV J774A:1 ¼ Average βV LDH J774A:1; βV AB J774A:1; βV ATP J774A:1; βV BRDU J774A:1
 
βV CELLS ¼ Average βV A549; βV J774A:1
 
2) Biological reactivity (βR) of the particles was
defined as any deviation from baseline in
cytotoxicity assays. βRCELLS was calculated by
averaging the absolute values (to capture any
deviation from baseline control levels) of the βV
according to:
βRA549 ¼ AVG βVLDH A549 ;j jβVAB A549 ;j jβVATP A549 ;j jβVBRDU A549
  




βR CELLS ¼ Average βR A549; βR J774A:1
 
3) An average potency for inflammation was
calculated within each cell line using +1*βI-V
for chemokines and pro-inflammatory cytokines
and −1*βI-V for anti-inflammatory cytokines. Two
different estimates of inflammatory potency were
calculated.
a) βI-VHI, an average considering the anti-
inflammatory effect of IL-10 (−1*βI-V for
IL10).
b) βI-VLO, an average considering anti-inflammatory
effects of IL-6 and IL-10.
4) βRCELLS and one of the two estimates of βI-V were
further integrated to calculate cell-specific Integrated
Beta potencies (Iβ). For example,
IβA549 HI ¼ Average βR A549; βI−V A549 HI
 
IβJ774A:1 LO ¼ Average βR J774A:1; βI−VJ774A:1 LO
 
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5) βR and βI-V were integrated across the cell lines as
follows.
βRCELLS ¼ Average βR A549; βR J774A:1; βAhR=20
 
βI−V HI ¼ Average βI−V A549 HI; βI−V J774A:1 HI
 
βI−V LO ¼ Average βI−V A549 LO; βI−V J774A:1 LO
 
βI−V CELLS ¼ Average βI−V HI; βI−V LO
 
6) βR and one of the two estimates of βI-V across cell
lines were further integrated to a grand Integrated
potency (Iβ). For example,
IβHI ¼ Average βR; βI−V HI
 
IβLO ¼ Average βR; βI−V LO
 
Iβ ¼ Average IβHI; IβLO
 
In a similar fashion, potency estimates were determined
for each in vivo endpoint. A potency estimate for acute
lung toxicity, βT BALB/c was determined from the average of
potencies for BAL endpoints (protein, LDH, 8-isoprostane,
neutrophils, macrophages, band cells, lymphocytes), while
a potency estimate for inflammation, βIBALB/c was deter-
mined from the potencies of particles for inducing the
release of cytokines and chemokines. As described for the
in vitro inflammatory potency estimates, βI HI, an average
considering the anti-inflammatory effect of IL-10 (−1*βI for
IL10) and βI LO, an average considering anti-inflammatory
effects of IL-6 and IL-10 were determined. An integrated
potency estimate that incorporates all in vivo data, Iβ BALB/c
was obtained from the average of βTBALB/c and βI BALB/c.
Statistical analyses
To ensure that assays were sensitive to the dose of par-
ticles, fold effect (FE) data were first analyzed by two-
way ANOVA with DOSE (0, 10, 20, 40, 80, 160 μg/well)
for in vitro data, or (0, 50, 100, 250 μg) for in vivo data,
and Particulate Matter (PM) as factors. Datasets not
meeting normality and equal variance were subjected to
log10, inverse or square root transformations (in the
order given) until the assumptions were met, or else
rank transformed prior to analyses. Pairwise multiple
comparisons were carried out using Tukey’s procedure
to elucidate the pattern of significant effects (α = 0.05).
The analyses were conducted using SigmaPlot, version
12.5 (Systat Software, Inc., San Jose, CA, USA).
Hierarchical clustering of the pattern of cytokine se-
cretion by A549 and J774 in response to particle ex-
posure were conducted using the GenePattern webtool
(http://www.broadinstitute.org/cancer/software/genepattern)
[29], and visualized as heatmaps using Java TreeView plu-
gin version 1.16.r2 (http://jtreeview.sourceforge.net) [30].
Linear regression between corresponding individual or
combined potency estimates in vitro and in vivo was
conducted using Sigmaplot v12.5 and depicted using
Microsoft Excel 2010 (Microsoft Corp., Redmond, WA,
USA). The strength of the relationship between every
two variables was described by a correlation coefficient
R and the significance of the hypothesis test by the p-
value of 0.05 (two-tailed test), or one-tailed test, where
applicable (i.e. consistent directionality of the variables).
The correlations presented are performed between in
vitro and in vivo matched endpoints across all particles,
based on individual particle potencies (Table 1) or com-
bined potency estimates (average of endpoints) for tox-
icity, inflammation, or integrated inflammation plus
toxicity (Tables 2, 3, and 5) all eight particles tested in vitro
(EHC-93, EHC-98, EHC-2000, SRM-1648, SRM-1649,
DWR1, TiO2, SiO2) or for five particles tested in vivo
(EHC-2000, SRM-1649, DWR1, TiO2, SiO2) for Table 5.
In addition, a selection of key potency estimates were
ranked and the strength of their relationship was reas-
sessed using Spearman’s rank-order correlation test (one-
tailed test), as the selected variables were observed to
have a consistent positive relationship, with a significance




Cytotoxicity and Ah receptor-dependent gene induction
Exposures of A549 and J774A.1 cells to particles revealed
cytotoxicity manifested by increased release of LDH into
cell culture supernatants (Fig. 1a and b) which was particle
type- and dose-dependent (two way ANOVA, PM×Dose,
p < 0.001), most prominent at the highest doses of the
particles. The LDH assay also revealed a significant de-
crease in LDH release in J774A.1 cells exposed to lower
Table 1 Pearson correlations for cytotoxic potency and cytokine inductions in cell lines exposed to particles
J774A.1 vs. A549 cells Assay Cytokine
AB ATP BrdU LDHc GM-CSF IL-1β IL-6 IL-10 TNF-α
R 0.478 0.703 0.792 0.455 0.071 −0.134 −0.051 0.446 −0.192
p (2-tailed) 0.231 0.052 0.019 0.257 0.867 0.752 0.905 0.268 0.649
Numbers in bold represent statistically significant correlations (p ≤ 0.05)
Correlations of corresponding individual endpoints across the cell lines were conducted
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and intermediate doses of urban particles in comparison
to baseline levels, but not in response to mineral particles
(Fig. 1a). This response was not observed in A549 cells
exposed to particles (Fig. 1b). Furthermore, we observed
reduced metabolic activity manifested by decreased resa-
zurin reduction (Additional file 2: Figure S1A and S1B),
cellular ATP levels (Additional file 2: Figure S1C and S1D)
as well as attenuated cell proliferation measured by BrdU
incorporation assay (Additional file 2: Figure S1E and
S1F). The presence of Ah receptor agonists was detected
in urban particles, but not mineral particles (two way
ANOVA, PM × Dose, p < 0.001) measured by AhR-
mediated luciferase reporter gene activity in H1L1.1c2
cells. A small but significant decrease in AhR-mediated
gene activity below baseline levels was detected in cells
exposed to the mineral particles (Fig. 1c).
Cytotoxic potency of each particle was represented by
βV, the rate of change of dose with respect to the loga-
rithm of fold-effect in a given assay. The potency esti-
mates were summarized in a heatmap (Fig. 2a). In both
cell lines, SRM-1648 and SRM-1649 urban particles were
more cytotoxic than the other particles, including the
EHC-type particles. TiO2 particles were also notably cyto-
toxic. The PM2.5 DWR1 and the CRI particles showed a
cluster of the lowest cytotoxic potency (Fig. 2a). This be-
havior of CRI in the present series of experiments was
atypical, as we expected CRI, based on our experimental
data, to be more cytotoxic in vitro than TiO2. In general,
there was no correlation of particle effects between the
two cell lines based on the corresponding individual
assays, with the exception of J774A.1 cell proliferation
response which was significantly correlated with A549 cell
proliferation estimate (R = 0.792; p = 0.019; Table 1).
Next, we combined cytotoxic potencies of the particles
from all in vitro endpoints in a given cell line into a
single βV value (Fig. 2b). The cell-type specific, com-
bined potency data outlined the cytotoxicity-based rank-
ing of the particles and indicated that overall, J774A.1
cells were more susceptible to particle effects than A549
cells. SRM- and EHC-type urban particles had compar-
able potency for Ah receptor-dependent gene induction
in H1L1.1c2 cells, which was markedly lower for the PM2.5
DWR1 particles, while a weak inhibitory potency was ob-
served in the case of the TiO2 and CRI particles (Fig. 2b).
Correlation analysis of the cell type-specific consensus
potency βV and biological reactivity of the particles βR (any
deviation from baseline control values) indicated that the
aggregated cytotoxic responses of A549 and J774A.1
cells were significantly correlated (p ≤ 0.05; Table 2).
Cytokine secretion in vitro
Release of cytokines into the culture medium upon cell
exposures was taken as a measure of inflammatory poten-
tial of the particles. Significant release of cytokines was in-
duced in response to particle exposures in both cell lines.
The observed responses were particle type- and/or dose-
specific as exemplified by IL-6 release (Fig. 3a and b; two
way ANOVA, PM×Dose, p < 0.001 for J774A.1; Dose
main effect, p < 0.001 for A549) and the other cytokines
(Additional file 3: Figure S2A to S2F; Additional file 4:
Figure S3A to S3G, two way ANOVA, p < 0.05). Cell
viability-adjusted inflammatory potency (βI-V; cytokine re-
lease) of the particles in the cells was visualized by a heat-
map. In both cell lines, the majority of the cytokines were
increased in response to particle exposures, except IL-10,
which generally remained unchanged or decreased in
J774A.1 cells (Fig. 4a and Additional file 3: Figure S2D;
two way ANOVA, PM×Dose, p = 0.026) and remained
unchanged or showed an increasing trend in A549 cells
(Fig. 4b and Additional file 4: Figure S3D; not significant).
Interleukin-6 and TNF-α showed the highest fold-
change from baseline values in J774A.1 cells (Fig. 3a
and Additional file 3: Figure S2F two way ANOVA,
PM ×Dose, p < 0.001) and clustered separately from the
rest of the cytokines (Fig. 4a). In A549 cells, IL-6, IL-8
Table 2 Pearson correlations for the combined in vitro potency
estimates of cell lines exposed to particles
J774A.1 vs. A549 cells Cytotoxicity Cytokine induction
βV βR βI-V βI-V LO βI-V HI
R 0.741 0.729 0.020 −0.089 −0.108
p (2-tailed) 0.035 0.040 0.963 0.835 0.800
Consensus cytotoxic potency βV is calculated from in vitro assays conducted in
individual cell lines
Biological reactivity of the particles βR represent absolute values of
cytotoxic potency
Consensus inflammatory potency βI-V represents the average unbiased particle
potency response for inducing a cytokine response, where LO and HI are the
lower and upper estimates of the index based on the pro- and anti-inflammatory
effects of some cytokines
Numbers in bold represent statistically significant correlations (p ≤ 0.05)






GM-CSF IL-1α IL-1β IL-6 IL-10 RANTES TNF-α GM-CSF IL-1β IL-6 IL-8 IL-10 MCP-1 MIP-1β TNF-α
R 0.699 0.645 0.718 0.867 −0.520 0.697 0.822 0.009 −0.517 −0.271 −0.484 −0.629 −0.090 −0.652 −0.523
p (2-tailed) 0.054 0.084 0.045 0.005 0.186 0.055 0.012 0.982 0.190 0.516 0.224 0.095 0.832 0.080 0.183
Numbers in bold represent statistically significant correlations (p ≤ 0.05)
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and TNF-α showed the highest fold-change from con-
trols (Fig. 3b, Additional file 4: Figure S3C and S3G;
two way ANOVA, PM × Dose, p < 0.05 for IL8; PM,
Dose main effects, p < 0.001 for TNF-α; Dose main
effect, p < 0.001 for IL-6) and clustered separately from
the remaining cytokines (Fig. 4b).
As was observed for most of the cytotoxicity endpoints,
particle effects on corresponding individual cytokine
Fig. 1 Lactate Dehydrogenase (LDH) release into cell culture supernatants of J774A.1 (a) and A549 (b) cells exposed for 24 h to particles, and Aryl
hydrocarbon receptor (AhR) induction by particles in the H1L1.1c2 cells after a 4 h exposure (c). For the LDH assay, data represent LDH release, adjusted for
total cellular LDH content. For the AhR assay, B[a]P was used as a positive control (0, 1, 10, 100 nM). All values are presented as average fold-effect (FE) over
control ± standard error (J774A.1, n = 4; A549, n = 3; H1L1.1c2, n = 3). Two way ANOVA; J774A.1, PM × Dose interaction, p < 0.001, asterisks (*) represent
effects significantly different from Dose 0 control, Tukey test, p < 0.05; A549, PM× Dose interaction, p < 0.001, asterisks (*) represent effects significantly
different from Dose 0 control, Tukey test, p < 0.05. Two way ANOVA; AhR, PM × Dose interaction, p < 0.001, asterisks (*) represent effects significantly
different from Dose 0 control, Tukey test, p < 0.05; one way ANOVA; B(a)P, Concentration, p = 0.016, Conc. 100 vs. 1 (†), Tukey test, p < 0.05
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Fig. 2 Heatmap with hierarchical cluster analysis of cytotoxic potency of particles in J774A.1 and A549 cells based on cytotoxicity assays (LDH
release, AB reduction, ATP content, BrdU incorporation) and AhR induction in H1L1.1c2 cells. Within the heatmap, green color represents
increased cytotoxic potency of particles (negative β) for majority of endpoints, except the AhR assay, where red color depicts increased potency
(positive β) (a). Consensus cytotoxic potency βV CELLS was calculated for each particle as average of all assay potencies, separately, for J774A.1 and
A549 cells. AhR induction potencies of the particles in H1L1.1c2 cells are also presented (b)
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release in A549 and J774A.1 cells were not correlated
(Table 1).
Notably, we observed a significant correlation between
AhR activity in H1L1.1c2 cells with IL-1β, IL-6 and
TNF-α release in J774A.1 cells (Table 3; R > 0.7, p ≤ 0.05),
but not with A549-produced cytokines.
Next, inflammatory potency βI-V values for all cytokines
were averaged within a cell line to obtain a consensus
inflammatory index presented in three scenarios that
assumed the general role of specific cytokines as anti- or
pro-inflammatory mediators. The lower inflammatory
estimate βI-V LO was computed by subtracting potency
values for IL-10 and IL-6 from the average estimate, as-
suming the dual role of IL-6 as a pleiotropic inflamma-
tory mediator [31, 32], while the higher inflammatory
estimate, βI-V HI was obtained by subtracting IL-10
potency value only. The inflammatory index revealed a
distinct profile of particle effects on cytokine release in
A549 and J774A.1 cells, highlighting a difference in
particle ranking.
For example, J774A.1 cells were more sensitive to the
effects of urban particles, especially EHC-98, EHC-2000
(Fig. 4c) whereas A549 cells were impacted most by CRI
and TiO2 mineral particles (Fig. 4d). Based on the
inflammatory scenarios, IL-6 release was the dominant
response in J774A.1 cells, with highest magnitude of
effect under the βI-V LO and βI-V HI inflammatory scenar-
ios, while its impact in A549 cells was minor. Correlation
analysis of the consensus βI-V inflammatory potency indi-
ces of the particles indicated that the aggregated inflam-
matory responses of the two cell lines were distinct
(Table 2).
The particles were screened for the presence of
endotoxin, biogenic material capable of inducing cyto-
kines in vitro and in vivo. Majority of the urban par-
ticles, including DWR1 had similar endotoxin content
Fig. 3 Interleukin (IL)-6 levels in cell culture supernatants from J774A.1 (a) and A549 (b) cells exposed to particles for 24 h. Values represent mean
fold effect (FE) over control ± standard error of the mean (n = 3). Two way ANOVA; J774A.1, PM × Dose interaction, p < 0.001, asterisks (*) represent
effects significantly different from Dose 0 control, Tukey test, p < 0.05; A549, Dose main effect, p < 0.001, Dose 160 vs. 0 or 10 (†), Tukey test, p < 0.05
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Fig. 4 Heatmap with hierarchical cluster analysis of cytotoxic potency of particles in J774A.1 (a) and A549 (b) cells based on cytokine release
after 24 h exposure to particles. Inflammatory potency estimate, βI-V for J774A.1 (c) and A549 (d) cells representing the average cytokine potency
adjusted for cell viability. The βI-V LO represents the lower estimate (IL-10 and IL-6 potency subtracted from average potency), while βI-V HI is the
higher estimate (IL-10 potency subtracted, IL-6 added to average potency). Within the heatmaps, red color represents increased inflammatory potency
of particles (increased cytokine/chemokine levels; positive β), whereas green color represents decreased inflammatory potency (negative β)
Breznan et al. Particle and Fibre Toxicology  (2016) 13:41 Page 11 of 24
(~70 – 130 EU/μg particles). SRM-1649 particles had no-
ticeably less endotoxin (3.0 EU/μg particles) while mineral
particles did not contain endotoxin (Table 4). A correlation
of endotoxin with the inflammatory potency estimates in
J774A.1 cells (βI-V J774A.1) and A549 cells (βI-V A549) revealed
a significant correlation with the inflammatory potency esti-
mate in J774A.1 cells (R = 0.729; p = 0.040), but not A549
cells (Table 5).
In vitro integrated particle potency
To summarize all cytotoxic particle effects in vitro across
cell types, biological reactivity βR CELLS was derived by
averaging the absolute values of the cytotoxic potencies,
βV of the particles in A549 and J774A.1 cells and the AhR
activity in H1L1.1c2 cells, assuming biological reactivity of
the particles as any deviation from baseline. From the βR
CELLS estimate, SRM-1648 and SRM-1649 particles had
the highest overall cell potency in contrast to DWR1 and
CRI particles which showed the lowest values (Fig. 5a).
Similarly, an inflammatory potency estimate βI-V CELLS,
was obtained for each particle by averaging the cell
viability-adjusted inflammatory potency values of the
particles across both cell lines for all cytokines detected,
for each inflammatory scenario (Fig. 5b). The estimates
impacted the magnitude of particle potency ranking, but
the ranking was comparable between the different scenar-
ios, where the urban particles, except EHC-93 were more
potent than mineral particles and DWR1.
Lastly, an overall integrated potency estimate, Iβ CELLS
of the particles was calculated by averaging the biological
reactivity, βR CELLS with inflammatory indices, βI-V CELLS-
for each particle (Fig. 5c). The Iβ CELLS profile was similar
to the profile of the inflammatory indices βI-V CELLS.
Toxicity of particles in vivo
BALB/c mice were exposed for 24 h to a subset of parti-
cles selected based on contrasting in vitro potency (EHC-
2000, SRM-1649, CRI, TiO2 and DWR1) by intratracheal
instillation (IT). Acute pulmonary toxicity was observed in
mice exposed to the high dose (250 μg) of the particles, as
shown by a general increase in BAL total protein (Fig. 6a;
two way ANOVA, Dose main effect, p < 0.001) and BAL
LDH (Additional file 5: Figure S4A; two way ANOVA,
PM×Dose, p = 0.035). A particle dose-dependent increase
in 8-isoprostane levels in blood plasma (Additional file 5:
Figure S4B; two way ANOVA, Dose main effect, p =
0.006) indicated a systemic oxidative stress after exposure
to particles. Neutrophil influx (Fig. 6b; two way ANOVA,
PM×Dose, p = 0.004) and a drop in lung-resident alveolar
macrophages (Additional file 5: Figure S4C; two way
ANOVA, Dose main effect, p < 0.001, PM main effect,
p = 0.018) were consistent with a particle challenge and
clearance after 24 h. Based on the in vivo toxic potency
estimates (β from cell differential counts and biochem-
ical endpoints), particles elicited an increase in acute
toxicity and cell injury marked by an increase in neu-
trophils and a decrease in macrophages. SRM-1649,
EHC-2000 and CRI clustered separately from less toxic
particles DWR1 and TiO2 (Fig. 6c).
Cytokine secretion in vivo
Significant particle type- and/or dose-dependent increase
in inflammatory mediators IL-6, IL-1α, IL-1β, IL-5, KC,
MIP-1α, RANTES and TNF-α (Fig. 7a and Additional file
6: Figure S5A to S5I); two way ANOVA, p < 0.05) were
measured in BAL fluid collected from mice exposed to
particles for 24 h, except IL-10 which was not altered
(Additional file 6: Figure S5E, not significant). Individual
in vivo inflammatory potency estimates (β from the cyto-
kine dose response) confirmed a particle-induced increase
for most of cytokines assessed. IL-6 and TNF-α were
highlighted as the most responsive cytokines to particle
exposures in vivo (Fig. 7b). SRM-1649 was the most po-
tent particle also based on the inflammatory potency esti-
mates, as it clustered distinctly from the remaining
particles (Fig. 7b).
In vivo integrated particle potency
All of the acute toxicity endpoints assessed in vivo were
averaged and depicted as βT BALB/c toxicity estimate for
each particle. The combined βT BALB/c estimate revealed
SRM-1649, EHC-2000 and CRI as highly potent particles,
compared to TiO2 and DWR1 (Fig. 8a). An inflammatory
potency estimate βI BALB/c was obtained by averaging the
dose response of all cytokines measured in BAL fluid. As
was done for in vitro cytokines, three scenarios were de-
scribed, βI LO BALB/c, βI HI BALB/c and their average, based
on subtraction of both, IL-10 and IL-6 (βI LO BALB/c), or
IL-6 only (βI HI BALB/c). The inflammatory potency esti-
mates βI BALB/c ranked identically to toxicity estimates βT
BALB/c, with no impact of the inflammatory potency sce-
narios on the ranking of particles (Fig. 8b). A final, in vivo
integrated potency estimate Iβ BALB/c was calculated by
averaging βT BALB/c and βI BALB/c for each particle (Fig. 8c),
as a consensus of all endpoints measured in vivo. Iβ BALB/c
estimate revealed SRM-1649, EHC-2000 and CRI as more
potent than TiO2 and DWR1 respectively, regardless of
the integrated potency estimate scenarios (Iβ HI, Iβ LO).
Table 4 Endotoxin content of particle stocks
PM EHC-93 EHC-98 EHC-2000 SRM-1648 SRM-1649 DWR1 CRI TiO2 PM buffer
Endotoxin (EU/μg PM) 100.0 ± 1.0 127.0 ± 1.0 112.0 ± 7.0 117. ± 0.4 3.0 ± 0.4 74.0 ± 10.0 ND ND 1.0 ± 4.0
ND not detectable
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Endotoxin content in particle preparations administered
to mice was not correlated with the combined in vivo
inflammatory potency estimates (βI BALB/c) of the particles
(Table 5).
In vitro and in vivo correlation
The relationship between particle effects in cells in vitro
and in BALB/c mice exposed to particles by intratracheal
instillation was explored by correlating the individual in
vitro and in vivo particle potency estimates, as well as
the in vitro and in vivo combined particle potency esti-
mates for the five particles tested by both approaches.
Majority of the individual particle potency estimates for
the corresponding endpoints were not correlated, with the
exception of a single association; the cellular LDH content
in J774A.1 cells, significantly correlated with LDH content
measured in BALB/c BAL fluid, (Additional file 1: Table S2;
R = 0.928, p = 0.023).
When the combined particle potency estimates in vitro
and in vivo were assessed by Pearson product–moment
correlation analysis for all particles tested, no statistically
significant correlations were observed between the corre-
sponding pairs of the key estimates, including the key esti-
mates; βR CELLS versus βT BALB/c (Fig. 9a and Additional
file 1: Table S3; R = 0.541, p = 0.173); βI-V CELLS versus
βI BALB/c (Fig. 9b and Additional file 1: Table S3; R =
0.639, p = 0.123) and Iβ CELLS versus Iβ BALB/c (Fig. 9c,
Additional file 1: Table S3; R = 0.668, p = 0.109). However,
a consistent increasing trend between these in vitro and in
vivo estimates was observed across the particles, where
DWR1 was ranked low, CRI and TiO2 were ranked inter-
mediate and SRM-1649 and EHC-2000 were ranked high
in potency (Fig. 9). Based on the observed trend in the
ranking of the particles, a directional (one-tailed) Spear-
man’s rank-order correlation analysis was conducted. The
analysis revealed that while the combined potency esti-
mates βR CELLS versus βT BALB/c remained non-correlated
(Table 6; R = 0.667, p = 0.109), correlations of βI-V CELLS
versus βI BALB/c and the integrated potency estimates Iβ
CELLS versus Iβ BALB/c approached the threshold for signifi-
cance α = 0.05 (Table 6; R = 0.8, p = 0.052). Finally, im-
proved correlation coefficients for the associations of the
combined particle potency estimates were observed when
mineral particle responses were excluded from the
estimates, albeit they were not statistically significant due
to low power (Additional file 1: Table S3); βR CELLS versus
βT BALB/c (R = 0.862, p = 0.169); βI-V CELLS versus βI BALB/c
(R = 0.888, p = 0.153) and Iβ CELLS versus Iβ BALB/c (R =
0.955, p = 0.096). Remarkably, CRI contributed most to
the decreased association of in vitro and in vivo potency
estimates, as exclusion of CRI only revealed improved
correlation comparable to the associations excluding both
mineral particles (Fig. 9, Additional file 1: Table S3);
βR CELLSversus βT BALB/c (R = 0.865, p = 0.068); βI-V CELLS
versus βI BALB/c (R = 0.800, p = 0.100) and Iβ CELLS versus
Iβ BALB/c (R = 0.895, p = 0.053). When the Spearman’s
rank-order correlation analysis was conducted on the par-
ticle ranks while excluding CRI, a statistically significant
rank-order was observed for βR CELLS versus βT BALB/
c(Table 6; R = 1.0, p < 0.001), while βI-V CELLS versus
βI BALB/cand the integrated potency estimates Iβ CELLS
versus Iβ BALB/c did not show a significant trend in a
correlation due to low power (Table 6; R = 0.8, p = 0.100).
Discussion
In this work we examined the level of concordance
between in vitro and in vivo responses to particulate
matter, to determine the potential of cell-based cytotox-
icity assays and cytokine/chemokine mediators in screen-
ing the toxicity of ambient particles. The dose response
results from the bioassays conducted in cell lines and from
intratracheal exposures of mice to particles were summa-
rized as slope-based measures of particle potency for each
endpoint. The potency values were combined within each
exposure model to obtain model-specific consensus po-
tency estimates of toxicity and inflammatory potential of
the particles, which were further combined into an overall
integrated potency estimate. The key derived particle
potency estimates were then assessed for correlation
across the in vitro and in vivo models.
We note that in the present series of experiments we
observed an atypically low in vitro cytotoxicity of the
CRI sample by comparison to TiO2. In vivo toxicity of
the same sample however was high, in accordance with
our historical observations and literature data on toxicity
of silica. Identity of the CRI samples was reconfirmed by
ICP-MS/AES analysis of the archived, diluted working
particle stocks that were used in the experiments. We
have also carefully validated the datasets, but could not
explain this atypical behavior of CRI in the series of in
vitro assays presented here, e.g. from computational er-
rors or material switching in assays, and therefore we re-
port the data as observed.
Urban and mineral particles induced toxicity in vitro
and in vivo (Figs. 2a and 6c). Cytotoxic responses in
vitro based on the individual endpoints were in general
different between epithelial cells and macrophages, with
the exception of the cell proliferation response (Table 1).
Table 5 Pearson correlations for the combined in vitro and
in vivo potency estimates versus endotoxin content of particles
Cytokine induction vs endotoxin βI-VJ774A.1 βI-V A549 βI BALB/c
R 0.729 −0.557 0.020
p (2-tailed) 0.040 0.152 0.963
Consensus inflammatory potency βI-V represents the average unbiased particle
potency response for inducing a cytokine response inflammatory potency
estimate βI-BALB/c is the average of all in vivo cytokines assessed in BAL fluid
Numbers in bold represent statistically significant correlations (p ≤ 0.05)
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Fig. 5 Biological reactivity estimate, βR CELLS was derived by averaging the cytotoxic potencies of the particles in A549 and J774A.1 cells, as well
as the AhR activity in H1L1.1c2 cells (a). A combined inflammatory estimate, βI-V CELLS, was obtained for each particle by averaging particle
inflammatory potency estimates adjusted for cell viability of J774A.1 and A549 cells. The βI-V LO represents the lower estimate (IL-10 and IL-6
potency subtracted from average potency), while βI-V HI is the higher estimate (IL-10 potency subtracted, IL-6 added to average potency) (b).
An integrated potency estimate of the particles, Iβ CELLS was determined by averaging the biological reactivity (cytotoxic potency) and inflammatory
estimates for each particle. Iβ LO represents the lower estimate (IL-10 and IL-6 potency subtracted from average potency). Iβ HI represents the higher
estimate (IL-10 potency subtracted, IL-6 added to average potency) (c)
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Fig. 6 (See legend on next page.)
Breznan et al. Particle and Fibre Toxicology  (2016) 13:41 Page 15 of 24
(See figure on previous page.)
Fig. 6 Total protein levels (a) in bronchioalveolar lavage (BAL) fluid of BALB/c mice exposed to particles for 24 h by intratracheal (IT) instillation.
Neutrophil cell counts (b) were determined from cytospin preparations of BAL. All values are presented as mean fold effect (FE) over control ± standard
error (n = 5). Two way ANOVA; Total protein, Dose main effect, p < 0.001, Dose 250 vs. 0, 50 or 100 (†), Tukey test, p < 0.001; Neutrophils, PM× Dose
interaction, p = 0.004, asterisks (*) represent effects significantly different from Dose 0 control, Tukey test, p < 0.05. Heatmap with hierarchical cluster
analysis of toxicity endpoints (cell differential counts and biochemical endpoints) (c) assessed in BALB/c mice 24 h after exposure to particles by
intratracheal instillation, summarized as potency estimates (slopes of the dose response). Within the heatmaps, red color represents increased toxic
potency of particles (increased biochemical measures or cell counts; positive β), whereas green color represents decreased toxic potency, with the
exception of macrophages, whereby green color representing a loss of cells is a measure of increased particle potency (negative β)
Fig. 7 Interleukin (IL)-6 (a) levels in BAL. All values are presented as mean fold effect (FE) over control ± standard error (n = 5). Two way ANOVA;
IL-6, PM × Dose interaction, p = 0.036, asterisks (*) represent effects significantly different from Dose 0 control, Tukey test, p < 0.05. Heatmap with
hierarchical cluster analysis of the individual inflammatory mediators (cytokines/chemokines) (b) assessed in BALB/c mice 24 h after exposure to
particles by intratracheal instillation, summarized as potency estimates (β from the cytokine dose response). Within the heatmaps, red color represents
increased inflammatory potency of particles (increased cytokine/chemokine levels; positive β), whereas green color represents decreased
inflammatory potency (negative β)
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Fig. 8 (See legend on next page.)
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The pulmonary alveolar epithelium (represented by the
A549 cell line) serves as a barrier/interface with the
outside environment, facilitates gas transfer and fluid
clearance, reduces surface tension and prevents expos-
ure to particles, toxicants and microbes [33]. It is a
resilient interface adapted to the mechanical forces of
ventilation and it is involved in pulmonary innate host
defense and tissue repair [34]. Alveolar epithelial cells
also produce a multitude of factors such as cytokines
and chemokines (e.g. MCP-1, GM-CSF, IL-8), which
impact the activity of pulmonary macrophages [35]. As
well, the cells express a variety of pattern recognition
receptors (e.g. NLRs, TLRs) for microbes and particu-
lates [34]. Pulmonary macrophages are phagocytic cells
involved in direct response to pathogens, antigen sens-
ing and activation of acquired and innate immunity,
and they serve as modulators of inflammation through
removal of pathogens, foreign materials and apoptotic
cells, and through production of a specific suite of
pro- and anti-inflammatory cytokines and chemokines
[34]. We used the J774A.1 murine macrophage cell line
as a model macrophage. Although the cells originate
from peripheral blood, they display the hallmarks
common to both blood-borne and lung-resident macro-
phages, including adherent, cytologic and phagocytic
properties [36].
The greater susceptibility of the macrophages to par-
ticle exposures compared to the epithelial cells observed
in this work (Fig. 3a) highlights the importance of using
functionally distinct cell types for hazard screening. The
innate phagocytic activity of macrophages results in
increased intracellular particle loads and cytotoxic ef-
fects that are more pronounced, than in epithelial cells
which do not undergo internalization of particles to the
same extent. Specifically, J774A.1 cell proliferation was
more impacted by particle exposures than A549 cells
(Additional file 2: Figure S1E and S1F). A greater de-
crease in proliferation and increase in apoptosis in
J774A.1 cells compared to A549 cells has also been
demonstrated after exposures to Mexico City PM10
particles [37]. Similarly, we have observed greater sensi-
tivity of J774A.1 cells than A549 cells to carbon nano-
tube exposures [38].
The impact of increased sensitivity of J774A.1 cells to
particle exposures was also revealed by a small decrease
of LDH release below control levels in cells exposed to
the intermediate doses of the urban particles (Fig. 1a). A
combination of the decreased cell proliferation from the
effects of the intermediate particle doses and a lack of
space for cell division in the nearly confluent wells
throughout the exposures likely resulted in an increased
cell death. The phenomenon was not observed in the
unexposed controls, or in cells exposed to the high doses
of the particles where the overt cytotoxicity led to high
LDH release, or in A549 cells that were less sensitive to
particle exposures.
Nevertheless, when the panel of in vitro toxicity end-
points (viability assays) was combined, the overall particle
potency was correlated across the cell lines (Table 2) re-
gardless of their functional difference, suggesting that the
cytotoxic profile of the particles reflects a more general
outcome (e.g. apoptosis), over different but converging
mechanisms of cytotoxicity. Although the particles affect
the cells through different pathways, with a sufficiently
broad array of assays it appears that the inherent cytotoxic
potential of the particles can be captured. This is con-
sistent with our previous observations that cytotoxicity
in vitro appears to correlate with time-weighted average
exposure limits for particles of occupational health
relevance [39].
In the present study, however, inflammatory potential
determined from the release of cytokines did not correl-
ate between the two cell lines, or with the overall cyto-
toxic potency of the particles (Table 2). This reveals that
functional impacts of particles on the cells (e.g. inflam-
matory response) are distinct from overt cytotoxicity and
will be sensitive to the cellular model used. Similarly, we
have shown previously that the impacts of urban particles
and minerals on the respiratory burst function of
stimulant-induced primary rat macrophages were not cor-
related with their cytotoxic effect determined by the
water-soluble tetrazolium salt XTT reduction assay [39].
In the present study, the cytokine profiles were more re-
flective of the functional specificity of the cell types. In
this context, A549 epithelial cells were similarly respon-
sive to mineral and urban air particles, in contrast to
J774A.1 macrophages which were more impacted by
the compositionally-complex urban air particles (Fig. 4).
The higher cytotoxicity of minerals in A549 cells com-
pared to J774A.1 cells highlights a potential importance
(See figure on previous page.)
Fig. 8 Toxic potency estimate in BALB/c, βTBALB/c was derived by averaging the potencies of the particles across the cell-specific and biochemical
measures from BALB/c mice exposed to the particles by intratracheal instillation (a). The combined inflammatory potency estimate, βIBALB/c, was
obtained for each particle by averaging the particle potencies for altered cytokine/chemokine levels in bronchioalveolar lavage. The βI LO represents
the lower estimate (IL-10 and IL-6 potency subtracted from average potency). The βI HI represents the higher estimate (IL-10 potency subtracted, IL-6
added to average potency) (b). The integrated potency estimate, Iβ BALB/c of the particles was determined by averaging the toxic and inflammatory
potency estimates for each individual particle. The Iβ LO represents the lower estimate (IL-10 and IL-6 potency subtracted from average potency), while
Iβ HI is the higher estimate (IL-10 potency subtracted, IL-6 added to average potency) (c)
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of particle surface interactions with cells that provide a
barrier-type function, such as lung epithelial cells.
Irregularity of insoluble particle surface at the molecu-
lar level can modulate particle cytotoxicity via surface-
associated free-radical formation [40]. Assessment of
inflammatory mediators was more reflective of organic
content of particles. Of note is that the AhR activity in
H1L1.1c2 cells was correlated with IL-1β, IL-6 and
TNF-α release in J774A.1 cells (Table 3). As shown
here, and previously [24], AhR agonists, such as poly-
cyclic aromatic hydrocarbons (PAHs) are a significant
component of particulate emissions. Besides its role in
xenobiotic metabolism, the Ah receptor is involved in
immunity and lung inflammation [41].
It has been shown that 2,3,7,8-tetrachlorodibenzo-p-
dioxin (TCDD)-activated AhR signaling participates in
the up-regulation of IL-1β, IL-6 and IL-8 expression
through activation of the nuclear factor (NF-kB) and
extra-cellular stimulus-activated kinase (ERK) signaling
cascades. Dioxins and PAHs are major components of
cigarette smoke. The AhR protein expression was up-
regulated in the presence of TNF-α and smoking and
exposure to TCDD enhanced rheumatoid arthritis (RA)
inflammatory processes in synovial tissue from RA
patients [42]. Interestingly, SiO2-induced acute lung in-
flammation is more severe, while fibrotic response is
attenuated in AhR−/− mice compared with C57Bl/6 mice,
suggesting a complex role for AhR in regulation of
inflammation [43]. The correlation with key pro-
inflammatory cytokines produced by J774A.1 cells upon
particle exposures in the present study (Table 3) suggests
that AhR signaling in lungs may represent an important
pathway in regulating inflammation triggered by emis-
sion particles. This notion requires further mechanistic
testing. Local production of inflammatory mediators is a
hallmark of pulmonary response to foreign materials.
These observations emphasize the need to capture a
diverse set of endpoints that are broadly reflective of the
functional specificity of cells and are tied to the particu-
lar hazard or route of exposure.
We have observed a small decrease in AhR-mediated
gene activity below control levels in cells exposed to CRI
and TiO2 particles (Fig. 1c), suggesting an inhibitory
effect of the particles in the Ah-dependent gene induc-
tion assay. Clarification of supernatants or cell lysates is
a recommended approach to facilitate fluorimetric-,
colorimetric-, or luminescence-based in vitro toxico-
logical assessments of optically/chemically active materials
such as nanoparticles, or their micron-sized counterparts
[28]. This assay protocol was adapted by introducing a
step to clarify cell lysates from particle residues by centrifu-
gation to prevent potential interference with the luciferase-
mediated reaction. Nonetheless, trace amounts of particles
may have remained in the cell lysates allowing for the pos-
sibility of a small underestimation of AhR-mediated gene
activity. Furthermore, a recent publication based on an
in silico model for Ah receptor docking by ligands
provides some evidence that TiO2-based nanoparticles
Fig. 9 Scatter plots of key corresponding in vitro and in vivo combined
particle potency estimates βR CELLS (in vitro assays) with βT BALB/c (in vivo
cell counts and biochemical endpoints) (a); βI-V CELLS (in vitro cytokines)
with βI BALB/c (in vivo cytokines) (b) and integrated particle potency
estimates, Iβ CELLS (averaged in vitro assays and cytokines) with Iβ BALB/c
(average of in vivo cell counts, biochemical endpoints and
cytokines) (c). Pearson correlation coefficients and p-values (1-tailed)
are presented for correlations of all particles (dashed grey line) and
particles excluding CRI (solid black line)
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could directly bind/adsorb to the Ah receptor with very
high affinity, although this notion has yet to be experi-
mentally validated in cellular models [44].
Endotoxin levels in urban particles were correlated
with the inflammatory index βI-V J774A.1 which is based
on the cytokine release by J774A.1 cells, but not with
A549-cell based inflammatory index βI-V A549 or the in
vivo inflammatory index βI BALB/c (Table 5). It is conceiv-
able that the endotoxin component in urban particles may
play a role in cytokine induction by macrophages. Macro-
phages express lipopolysaccharide-responsive Toll-like re-
ceptor 4 on their cell surface [45]. Endotoxin-associated
induction of pro-inflammatory cytokines TNF-α, IL-1
and IL-6 can be inhibited by the antimicrobial agent
polymyxin B in alveolar macrophages exposed to
urban particles [46]. However, only a small amount of
endotoxin (~0.1 EU/mg particle) was detected in the
urban particles tested (Table 4). The trace levels in
EHC-93 particles (a particle used in the present study) do
not have appreciable effects on mRNA expression of pro-
inflammatory genes in human bronchial epithelial cells
[47]. Also, endotoxin at comparable levels did not activate
the bone marrow (measure of systemic inflammatory re-
sponse) of rabbits upon its instillation in lungs of the ani-
mals [48]. In addition, in the present study, mineral
particles were highly potent in triggering cytokine release
both in vitro and in vivo despite the absence of endotoxin
(Figs. 4 and 7). Conversely, SRM-1649 particles had ~35-
fold lower endotoxin content than the other urban parti-
cles, but SRM-1649 induced cytokines at the same magni-
tude as in cells exposed to the other urban particles. Thus
other particle components likely contributed to the release
of inflammatory mediators by cells observed in our study.
Up-regulation of genes for cytokines and chemokines in
cells in vitro (e.g. bronchial epithelial cells) has been ob-
served in response to various subcomponents of particu-
late matter including carbon-core, transition metals or
polyaromatic hydrocarbons [49].
With the exception of the mineral particles, the coarse
and fine urban particles tested here represent complex
mixtures containing both soluble and insoluble fractions,
which will contribute to the potency in vitro to varied
extents due to differences in uptake mechanisms,
molecular targets of the various particle components,
corona formation or differences in the settling rate of
the denser particle components. Therefore, homogeneity
of particle suspension delivered to the cells was achieved
by sonication of the particles prior to delivery. However,
it has to be noted that, even with the in vivo delivery of
environmental particles, similar differences of soluble
and insoluble fractions of the particulate mixture will be
encountered. Specifically, the issue of dilution of soluble
components of ambient particles in the culture medium
has been examined in previous work [24]. By ensuring
Table 6 Rank order correlations for the combined in vitro (cell lines) and in vivo (BALB/c mouse) particle potency estimates for all
particles (PM) and excluding cristobalite (CRI)
Particle potency estimates Particles Ranking in vitro Ranking in vivo Rank-order correl. (All PM)a Rank-order correl. (no CRI)b
R p (1-tailed) R p (1-tailed)
Toxicity
βR CELLS vs. βT BALB/c
CRI 5 - 3 -
DWR1 4 (4) 5 (4)
EHC-2000 2 (2) 2 (2) 0.667 0.109 1.000 <0.001
SRM-1649 1 (1) 1 (1)
TiO2 3 (3) 4 (3)
Inflammation
βI-V CELLS vs. βI BALB/c
CRI 4 - 3 -
DWR1 5 (4) 5 (4)
EHC-2000 1 (1) 2 (2) 0.800 0.052 0.800 0.100
SRM-1649 2 (2) 1 (1)
TiO2 3 (3) 4 (3)
Integrated Potency
Iβ CELLS vs. Iβ BALB/c
CRI 4 - 3 -
DWR1 5 (4) 5 (4)
EHC-2000 1 (1) 2 (2) 0.800 0.052 0.800 0.100
SRM-1649 2 (2) 1 (1)
TiO2 3 (3) 4 (3)
Particle ranking based on integrated particle potency estimates across cell types and in vitro or in vivo endpoints, where the lowest number represents the most
potent particle
The ranking outside brackets includes all PM, the ranking within brackets excludes CRI
aSpearman’s rank-order correlation and p-values (1-tailed) on ranked corresponding in vitro and in vivo potency estimates for all PM, bexcluding CRI
Numbers in bold represent statistically significant correlations (p ≤ 0.05)
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internal consistency in assay conditions, the biases, if
present, will be systematic, affecting all particles studied.
Instillation of particles in lungs of BALB/c mice led to
elevated neutrophil counts and cytokine levels in BAL
fluid, and generally unremarkable changes in biochemical
markers, a profile consistent with mild, acute pulmonary
inflammation at 24 h post-exposure. This was accompan-
ied by a decrease in alveolar macrophages in BAL fluid,
consistent with macrophage-associated pulmonary clear-
ance of foreign particles (Fig. 6). Determination of neutro-
phil counts in lung lavage fluid represents a key, sensitive
response to pulmonary instillation of urban and mineral
particles [50, 51]. Recruitment of neutrophils in response
to acute particle exposure is a consequence of a local lung
inflammatory cascade aimed at the clearance of the
foreign materials and macrophage apoptotic bodies. In
our study, production of the inflammatory mediators
accompanied the observed cellular differential profile
measured in BAL fluid upon instillation with particles
(Fig. 7). The in vivo response to particles was dominated
by IL-6 and TNF-α release, along with other cytokines,
including KC (murine IL-8 homolog), indicators of the
presence of acute inflammation. Increases in BAL TNF-α,
IL-6 and KC have been also observed by others in C57Bl/
6 J mice instilled with fine and coarse urban particles
collected from European cities [52].
A European study conducted using particles collected
in different seasons from urban centers along with EHC-
93 Ottawa urban particles examined the role of physico-
chemical particle properties in modulating the production
of cytokines in vitro and on in vivo inflammation in rat
lungs as well as adjuvant potency in allergic mouse
models. The in vitro assays of cytokine production (IL-6,
IL-8, TNF-α, MIP-2) in macrophage and lung epithelial
cells exposed to coarse and fine particles for 20 h corre-
lated with in vivo inflammation endpoints (TNF-α, MIP-2,
albumin, Clara cell protein 16) measured in BAL of rats at
24 h after intratracheal exposure to the same particles. In
contrast, poor correlation was observed between different
endpoints from in vivo allergy models and inflammatory
parameters, suggesting that a variety of endpoints are
needed to assess the potential hazard of particles [19].
In the present study, we have observed a significant
correlation of LDH content in J774A.1 macrophages
with LDH in BALB/c lung lavage (Additional file 1:
Table S2). Such relationship can be conceptually simpler
to understand, i.e. increased potential of particles to per-
turb macrophage cell membranes in vitro correlates with
increased potential to damage cell membranes of particle-
laden lung macrophages and neutrophils, however further
study is needed to ascertain the mechanisms. Therefore,
we have combined the in vitro endpoints in a manner to
capture the general cytotoxicity of the particles and the
functionally-specific aspects (inflammatory potential) in a
meaningful manner that can be subsequently deconstructed
to explore the mechanisms of action of the variety of parti-
cles, and to facilitate the comparison to in vivo responses.
Our combined estimates of particle potency in vitro
and in vivo for toxicity; (βR, βT) were not significantly
correlated. However, the combined potency estimates for
inflammatory potential (βI-V, β I) and the integrated particle
potency estimates (Iβ) that further combined the toxicity
and inflammatory bioassay response potency estimates
approached the threshold for significance α = 0.05 in a
correlation (Table 6; R = 0.8, p = 0.052). The lack of strong
associations may be due to insufficient power to obtain
statistical significance. Although eight particles (with six
urban particles) were screened in vitro, for workload rea-
sons a subset of five particles only (including three urban
particles) was tested in vivo, an issue that highlights the
impracticality of in vivo assays for high-throughput testing.
A better correlation may also have been achieved with
additional in vivo time points, capturing different stages of
the transient particle-induced in vivo toxicity and inflam-
mation profile. The use of a single species could also have
potentially led to higher in vitro/in vivo correlations. How-
ever, employing different, routinely used species (mouse
and human) enabled the assessment of whether integrating
toxicity endpoints originating from widely varied cell types
(functionality and species differences) would constitute a
robust in vitro surrogate that can be useful in predicting in
vivo responses of biological and health relevance. As previ-
ously seen, the ranking of potencies of a series of particles
was comparable between the mouse macrophage cell line
J774A.1 and the human cell line THP-1 (unpublished ob-
servations). There are other variables beyond species that
affect potency estimates, such as cell seeding or monolayer
density at time of exposure, etc.
As illustrated by our results in vitro, toxicological re-
sponses of cells to particles of complex composition,
such as urban particles may be governed by mechanisms
distinct from responses to particles that are more homo-
geneous, such as minerals. The array of potential mecha-
nisms that may reflect the responses of vastly different
particle types may not have been adequately captured in
our panel of assays. Nevertheless, the more potent mate-
rials that ranked highly in vitro were also highly ranked
in vivo, while the less potent particles were ranked low,
except TiO2 and CRI particles that were less consistent
in vitro and in vivo (Fig. 9). Retesting the model with
more particles of comparable physicochemical complex-
ity (i.e. urban particles) and additional relevant assays
may provide an improved model performance.
Conclusion
The challenge with investigating the relative risk to health
of different particulate source emissions is the reliability of
the cytotoxicity models applied, with respect to sensitivity
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of the cells and potential bias for specific potency determi-
nants. A test system should be sensitive to most if not all
potency determinants in particles of different origins and
should be relevant to the pathways of toxicity in humans
leading to adverse health outcomes. In order to achieve
this, computational approaches are needed, to reduce the
complex datasets, dose responses, multiple assays and cell
lines into meaningful descriptors of potency. Therefore,
an approach which combines tissue-specific, functionally
distinct cell types with a diverse set of assays that capture
convergent toxicity pathways and risk-specific mecha-
nisms forms an ideal basis in a tiered strategy for hazard
identification and toxicity testing. It remains difficult to
broadly capture most of the key events that underlie ad-
verse pulmonary reactions. This may require the inclusion
of a greater variety of assays, such as air-liquid interface
models, more cell types and particles, or more relevant
particles in the model.
More physiologically relevant cell-cell interaction-based
models (e.g. co-cultures, or 3D spheroids grown on recon-
stituted basement membranes) show promise in capturing
additional factors that may narrow the gap between
in vitro and in vivo testing [53, 54], the latter representing
the currently accepted basis of risk assessment regimes.
By design, in vitro-based systems are highly relevant for
high-throughput applications (e.g. EPA ToxCast, Tox21
initiatives) and high-content data (genomic, proteomic
profiling) which are required to address the current chal-
lenge posed by the large number of data-poor chemicals,
that must undergo toxicological risk-based prioritization
and assessment. More comprehensive evaluations of the
predictive potential of in vitro assays for disease-relevant
adverse outcomes will be needed for in vitro assays to be-
come a trusted and practical tool in regulatory risk assess-
ment. Although in vitro screening approaches may not yet
fully replace the need for in vivo regulatory toxicology
testing, they could provide an effective component of a
multi-tiered testing approach.
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Additional file 1: Table S1. Elemental composition and size of the urban
particulate matter and mineral particles. Table S2. Pearson correlations for
cytotoxic potency and cytokine inductions in cell lines versus BALB/c mice
exposed to particles. Table S3. Pearson correlations for the combined
average in vitro (cell lines) and in vivo (BALB/c mice) particle potency
estimates. (DOC 77 kb)
Additional file 2: Figure S1. Resazurin reduction by J774A.1 (A) and
A549 (B) cells exposed to particles. Average fold-effect (FE) over control ±
standard error values are shown (n = 5). ATP content of J774A.1 (C) and
A549 (D) cells exposed to particles. (n = 3). Proliferation in J774A.1 (E) and
A549 (F) cells exposed to particles. (n = 3). Two way ANOVA; Resazurin
assay, J774A.1, PM main effect, p < 0.001, SRM-1648 vs. DWR1, EHC-98 or
EHC-2000 (†), SRM-1649 vs. DWR1, EHC-93, EHC-98, EHC-2000, TiO2 or CRI
(‡), Tukey test, p < 0.05, Dose main effect, p < 0.001, Doses 0, 10 or 20 vs.
40, 80 or 160 (#), Dose 40 vs. 80 or 160 (not shown), Dose 80 vs. 160 (not
shown), Tukey test, p < 0.05; Resazurin assay, A549, PM × Dose interaction,
p = 0.001, asterisks (*) represent effects significantly different from control,
Tukey test, p < 0.05. ATP assay, J774A.1, PM main effect, p < 0.001, EHC-98
vs. SRM-1648, SRM-1649 or EHC-2000 (†), SRM-1649 vs. DWR1, TiO2 or
EHC-93 (‡), Tukey test, p < 0.05, Dose main effect, p < 0.001, Dose 160 vs. all
doses (#), Tukey test, p < 0.001; ATP assay, A549, PM main effect, p < 0.001,
DWR1 vs. all particles (†), EHC-93 vs. SRM-1649, CRI or TiO2 (‡), Tukey
test, p < 0.05, Dose main effect, p < 0.001, Dose 10 vs. 0, 40, 80 or
160 (not shown), Dose 20 vs. 80 (not shown), Dose 160 vs. 0, 20, 40
or 80 (#), Tukey test, p < 0.05. BrdU assay, J774A.1, PM main effect, p
< 0.001, DWR1 or CRI vs. EHC-93, EHC-98, EHC-2000, SRM-1648, SRM-
1649 or TiO2 (†), Tukey test, p < 0.05, Dose main effect, p < 0.001,
Doses 0 or 10 vs. 20, 40, 80 or 160 (‡), Doses 20 or 40 vs. 80 or 160
(not shown), Dose 80 vs. 160 (not shown), Tukey test, p < 0.05; BrdU
assay, A549, Dose main effect, p < 0.001, Dose 10 vs. 0, 20, 80 or 160
(†), Dose 40 vs. 80 or 160 (‡), Tukey test, p < 0.05. (DOCX 80 kb)
Additional file 3: Figure S2. Granulocyte-Macrophage Colony-Stimulating
Factor (GM-CSF) (A), interleukin (IL)-1α (B), IL-β (C), IL-10 (D), Regulated upon
Activation Normal T cell Expressed and Secreted (RANTES) (E) and Tumor
Necrosis Factor (TNF)-α (F) levels in cell culture supernatants of J774A.1 cells
exposed to particles for 24 h. Values are presented as mean fold-effect (FE)
± standard error (n = 3). Two way ANOVA; GM-CSF, PM × Dose interaction,
p = 0.001, asterisks (*) represent effects significantly different from Dose 0
control, Tukey test, p < 0.05; IL-1α, PM × Dose interaction, p < 0.001, asterisks
(*) represent effects significantly different from Dose 0 control, Tukey test,
p < 0.05; IL-β, PM × Dose interaction, p < 0.001, asterisks (*) represent effects
significantly different from Dose 0 control, Tukey test, p < 0.05; IL-10, PM ×
Dose interaction, p = 0.026, asterisks (*) represent effects significantly differ-
ent from Dose 0 control, Tukey test, p < 0.05; RANTES, PM × Dose interaction,
p < 0.001, asterisks (*) represent effects significantly different from Dose 0
control, Tukey test, p < 0.05; TNF-α, PM × Dose interaction, p < 0.001, asterisks
(*) represent effects significantly different from Dose 0 control, Tukey test,
p < 0.05. (DOCX 73 kb)
Additional file 4: Figure S3. Granulocyte-Macrophage Colony-
Stimulating Factor (GM-CSF) (A), interleukin (IL)-1β (B), IL-8 (C), IL)-10 (D),
Monocyte Chemoattractant Protein (MCP)-1 (E), Macrophage Inflammatory
Protein (MIP)-1β (F) and Tumor Necrosis Factor (TNF)-α (G) levels in cell
culture supernatants of A549 cells exposed to particles for 24 h. Values are
presented as mean fold-effect (FE) ± standard error (n = 3). Two way ANOVA;
GM-CSF, Dose main effect, p < 0.001, Dose 160 vs. 0, 10 or 40 (†), Dose 10 vs.
40 (not shown), Tukey test, p < 0.05; IL-1β, PM main effect, p = 0.004, TiO2 vs.
DWR1 or EHC-93 (†), Tukey test, p < 0.05, Dose main effect, p < 0.001, Doses
40 or 160 vs. 0 or 10 (‡), Tukey test, p < 0.05; IL-8, PM × Dose interaction,
p = 0.016, asterisks (*) represent effects significantly different from Dose 0
control, Tukey test, p < 0.05; IL-10, not statistically significant; MCP-1,
PM × Dose interaction, p = 0.001, asterisks (*) represent effects significantly
different from Dose 0 control, Tukey test, p < 0.05; MIP-1β, PM main effect,
p = 0.014, TiO2 vs. EHC-93 (†), Tukey test, p < 0.05, Dose main effect,
p = 0.023, Dose 160 vs. 10 (‡), Tukey test, p < 0.05; TNF-α, PM main effect,
p < 0.001, TiO2 vs. DWR1, EHC-93 or EHC-2000 (†), CRI vs. DWR1 (‡), Tukey
test, p < 0.05, Dose main effect, p < 0.001, Dose 0 vs. 10, 40 or 160 (#),
Dose 10 vs. 40 (not shown), Dose 160 vs. 10 or 40 (not shown), Tukey test,
p < 0.05. (DOCX 85 kb)
Additional file 5: Figure S4. Lactate dehydrogenase (LDH) levels in
bronchioalveolar lavage (BAL) fluid (A), 8-isoprostane levels in blood
plasma (B), Macrophage (C), Band cell (D) and lymphocyte (E) counts
in BAL fluid from BALB/c mice exposed to particles by intratracheal
instillation, at 24 h post-exposure. Values represent mean fold-effect (FE)
± standard error of the mean (n = 5). Two way ANOVA; LDH, PM × Dose
interaction, p = 0.035, asterisks (*) represent effects significantly different
from Dose 0 control, Tukey test, p < 0.05; 8-isoprostane, Dose main effect,
p = 0.006, Dose 0 vs. 100 (†), Tukey test, p = 0.004; Macrophages, PM main
effect, p = 0.018, TiO2 vs. SRM-1649 (†), Tukey test, p = 0.049, Dose main
effect, p < 0.001, Dose 0 vs. 50, 100 or 250 (‡), Dose 50 vs. 250 (#), Tukey
test, p < 0.05; Band cells, Dose main effect, p < 0.001, Dose 0 vs. 50 or
100 (†), Tukey test, p < 0.001; Lymphocytes, Not statistically significant.
(DOCX 63 kb)
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Additional file 6: Figure S5. Granulocyte Macrophage-Colony Stimulat-
ing Factor (GM-CSF) (A), interleukin (IL)-1α (B), IL-1β (C), IL-5 (D), IL-10 (E),
Keratinocyte-derived Chemokine (KC) (F), Macrophage Inflammatory Protein
(MIP)-1α (G), Regulated upon Activation Normal T cell Expressed and
Secreted (RANTES) (H) and Tumor Necrosis Factor (TNF)-α (I) levels in
bronchioalveolar lavage fluid of BALB/c mice exposed to particles by
intratracheal instillation, at 24 h post-exposure. Values represent mean
fold-effect (FE) ± standard error of the mean (n = 5). Two way ANOVA;
GM-CSF, Dose main effect, p < 0.001, Dose 250 vs. 0 (†), Dose 250 vs. 50 (‡),
Tukey test, p < 0.05; IL-1α, PM main effect, p < 0.001, CRI, EHC-2000 or
SRM-1649 vs. DWR1 or TiO2 (†), Tukey test, p < 0.05, Dose main effect,
p < 0.001, Dose 0 vs. 50, 100 or 250 (‡), Dose 50 vs. 100 (not shown),
Dose 250 vs. 50 or 100 (not shown), Tukey test, p < 0.05; IL-β, PM × Dose
interaction, p = 0.015, asterisks (*) represent effects significantly different
from Dose 0 control, Tukey test, p < 0.05; IL-5, PM × Dose interaction,
p = 0.007, asterisks (*) represent effects significantly different from Dose 0
control, Tukey test, p < 0.05; IL-10, not statistically significant; KC, PM × Dose
interaction, p = 0.001, asterisks (*) represent effects significantly different
from Dose 0 control, Tukey test, p < 0.05; MIP-1α, PM × Dose interaction,
p < 0.001, asterisks (*) represent effects significantly different from Dose 0
control, Tukey test, p < 0.05; RANTES, Dose main effect, p < 0.001, Dose 0 vs.
100 or 250 (†), Dose 250 vs. 50 or 100 (‡), Tukey test, p < 0.05; TNF-α, PM
main effect, p = 0.003, TiO2 vs. CRI, EHC-2000 or SRM-1649 (†), Tukey test,
p < 0.05, Dose main effect, p < 0.001, Dose 0 vs. 50, 100 or 250 (‡), Dose 250
vs. 50 (#), Tukey test, p < 0.05. (DOCX 100 kb)
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